Discovery of thienoimidazole-based HCV NS5A genotype 1a and 1b inhibitors

被引：0

作者：

Giroux, Simon ^{[1
]}

Xu, Jinwang ^{[1
]}

Reddy, T. Jagadeeswar ^{[2
]}

Morris, Mark ^{[1
]}

Cottrell, Kevin M. ^{[1
]}

Cadilhac, Caroline ^{[2
]}

Henderson, James A. ^{[1
]}

Nicolas, Olivier ^{[3
]}

Bilimoria, Darius ^{[3
]}

Mani, Nagraj ^{[4
]}

Ewing, Nigel ^{[5
]}

Shawgo, Rebecca ^{[5
]}

L'Heureux, Lucille ^{[3
]}

Selliah, Subajini ^{[3
]}

Grillot, Anne-Laure ^{[1
]}

Bennani, Youssef L. ^{[2
]}

Maxwell, John P. ^{[1
]}

机构：

[1] Vertex Pharmaceut, Med Chem, Boston, MA 02210 USA

[2] Vertex Pharmaceut Canada Inc, Med Chem, Laval, PQ H7V 4A7, Canada

[3] Vertex Pharmaceut Canada Inc, Biol, Laval, PQ H7V 4A7, Canada

[4] Vertex Pharmaceut, Biol, Boston, MA 02210 USA

[5] Vertex Pharmaceut, Drug Metab & Pharmacokinet, Boston, MA 02210 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

79-MEDI

引用

页数：1

共 50 条

[11] "OTHELLO HYPOTHESIS" INVOLVED IN THE DEVELOPMENT OF RAVS TOLERANT TO NS5A INHIBITORS IN PATIENTS WITH GENOTYPE 1B HCV INFECTION
Uchida, Y.
Kouyama, J-I.
Naiki, K.
Sugawara, K.
Inao, M.
Imai, Y.
Nakayama, N.
Mochida, S.
JOURNAL OF HEPATOLOGY, 2016, 64 : S410 - S411
[12] Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir
Liu, Rong
Curry, Stephanie
McMonagle, Patricia
Yeh, Wendy W.
Ludmerer, Steven W.
Jumes, Patricia A.
Marshall, William L.
Kong, Stephanie
Ingravallo, Paul
Black, Stuart
Pak, Irene
DiNubile, Mark J.
Howe, Anita Y. M.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) : 6922 - 6929
[13] Discovery of fluorobenzimidazole HCV NS5A inhibitors
Randolph, John
Flentge, Charles
Patel, Sachin
Nelson, Lissa
Mondal, Rubina
Mistry, Neeta
Reisch, Tom
Dekhtyar, Tatyana
Krishnan, Preethi
Pilot-Matias, Tami
Beno, David
Wagner, Rolf
Kati, Warren
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[14] Discovery of fluorobenzimidazole HCV NS5A inhibitors
Randolph, John T.
Flentge, Charles A.
Donner, Pamela
Rockway, Todd W.
Patel, Sachin V.
Nelson, Lissa
Hutchinson, Douglas K.
Mondal, Rubina
Mistry, Neeta
Reisch, Thomas
Dekhtyar, Tatyana
Krishnan, Preethi
Pilot-Matias, Tami
Stolarik, Deanne F.
Beno, David W. A.
Wagner, Rolf
Maring, Clarence
Kati, Warren M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (22) : 5462 - 5467
[15] Discovery of potent HCV NS5A inhibitors with pan-genotype activity
Yu, Wensheng
Chen, Lei
Dwyer, Michael
Keertikar, Kerry
Kim, Seong Heon
Lavey, Brian
Nair, Anilkumar
Rizvi, Razia
Rosenblum, Stuart
Selyutin, Oleg
Shankar, Bandarpalle
Tong, Ling
Wong, Michael
Yang, De-Yi
Zeng, Qingbei
Zhou, Guowei
Hu, Bin
Zhong, Bin
Wang, Dahai
Hao, Jinglai
Liu, Rong
Agrawal, Sony
Carr, Donna
Rokosz, Laura
Curry, Stephanie
McMonagle, Patricia
Ingravallo, Paul
Lahser, Fred
Asante-Appiah, Ernest
Nomeir, Amin
Coburn, Craig
Kozlowski, Joseph
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[16] An mTor-based immunosuppression reduces the antiviral efficacy of NS3/4A and NS5A inhibitors for HCV genotype 1b treatment in vitro
Frey, Alexandra
Walker, Andreas
Timm, Joerg
Gerken, Guido
Wedemeyer, Heiner
Herzer, Kerstin
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E829 - E829
[17] Discovery of potent macrocyclic HCV NS5A inhibitors
Yu, Wensheng
Vibulbhan, Bancha
Rosenblum, Stuart B.
Martin, Gregory S.
Vellekoop, A. Samuel
Holst, Christian L.
Coburn, Craig A.
Wong, Michael
Selyutin, Oleg
Ji, Tao
Zhong, Bin
Hu, Bin
Chen, Lei
Dwyer, Michael P.
Jiang, Yueheng
Nair, Anilkumar G.
Tong, Ling
Zeng, Qingbei
Agrawal, Sony
Carr, Donna
Rokosz, Laura
Liu, Rong
Curry, Stephanie
McMonagle, Patricia
Ingravallo, Paul
Lahser, Fred
Asante-Appiah, Ernest
Fells, James
Kozlowski, Joseph A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (15) : 3793 - 3799
[18] Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine
Latimer, Brian
Toporovski, Roberta
Yan, Jian
Pankhong, Panyupa
Morrow, Matthew P.
Khan, Amir S.
Sardesai, Niranjan Y.
Welles, Seth L.
Jacobson, Jeffrey M.
Weiner, David B.
Kutzler, Michele A.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2357 - 2365
[19] The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors
Lambert, Sebastian M.
Langley, David R.
Garnett, James A.
Angell, Richard
Hedgethorne, Katy
Meanwell, Nicholas A.
Matthews, Steve J.
PROTEIN SCIENCE, 2014, 23 (06) : 723 - 734
[20] Investigating Genotype 1a HCV Drug Resistance in NS5A Region via Bayesian Inference
Fu, Yao
Chen, Gang
Fu, Lizhi
Zhang, Jing
TSINGHUA SCIENCE AND TECHNOLOGY, 2015, 20 (05) : 484 - 490

← 1 2 3 4 5 →